Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2353)
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
443,707
Price
$33.25
Total Value
$14.75M
Shares Held After
174,144
% of Holdings
71.8%
Edwards Lifesciences Corp (EW)
BOBO DONALD E JR — CVP,Strategy/Corp Development
Shares
11,340
Price
$85.93
Total Value
$974.43K
Shares Held After
21,266
% of Holdings
34.8%
Monte Rosa Therapeutics, Inc. (GLUE)
Dunn Edmund — Principal Accounting Officer
Shares
536
Price
$17.50
Total Value
$9.38K
Shares Held After
22,693
% of Holdings
2.3%
LEMAITRE VASCULAR INC (LMAT)
LeMaitre George W — Director
Shares
55,930
Price
$107.81
Total Value
$6.03M
Shares Held After
1,476,500
% of Holdings
3.6%
TransMedics Group, Inc. (TMDX)
Hernandez Gerardo — Chief Financial Officer
Shares
375
Price
$139.12
Total Value
$52.17K
Shares Held After
14,689
% of Holdings
2.5%
TransMedics Group, Inc. (TMDX)
Ranganath Anil P. — Senior Vice President, General Counsel and Secretary
Shares
864
Price
$139.12
Total Value
$120.20K
Shares Held After
13,091
% of Holdings
6.2%
TransMedics Group, Inc. (TMDX)
Corcoran Nicholas — SVP of Supply Chain and Operations
Shares
2,966
Price
$139.12
Total Value
$412.63K
Shares Held After
29,831
% of Holdings
9.0%
Alkermes plc. (ALKS)
Parisi Samuel Joseph — VP, Finance (Interim PAO)
Shares
6,890
Price
$29.29
Total Value
$201.81K
Shares Held After
7,717
% of Holdings
47.2%
Alkermes plc. (ALKS)
Nichols Christian Todd — SVP, Chief Commercial Officer
Shares
6,000
Price
$30.00
Total Value
$180.00K
Shares Held After
109,769
% of Holdings
5.2%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
10,000
Price
$15.72
Total Value
$157.20K
Shares Held After
1,169,524
% of Holdings
0.8%
AMICUS THERAPEUTICS, INC. (FOLD)
Campbell Bradley L — Director
Shares
22,500
Price
$14.35
Total Value
$322.84K
Shares Held After
998,680
% of Holdings
2.2%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
406
Price
$71.66
Total Value
$29.09K
Shares Held After
181,371
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
994
Price
$70.45
Total Value
$70.03K
Shares Held After
181,777
% of Holdings
0.5%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
300
Price
$69.43
Total Value
$20.83K
Shares Held After
182,771
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
300
Price
$68.27
Total Value
$20.48K
Shares Held After
183,071
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
37
Price
$332.64
Total Value
$12.31K
Shares Held After
36,606
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
94
Price
$331.93
Total Value
$31.20K
Shares Held After
36,643
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
36,737
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
36,818
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
36,988
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
37,088
% of Holdings
0.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
37,417
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
37,809
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
38,067
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
38,157
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
160
Price
$332.64
Total Value
$53.22K
Shares Held After
98,628
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
399
Price
$331.93
Total Value
$132.44K
Shares Held After
98,788
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
346
Price
$330.85
Total Value
$114.47K
Shares Held After
99,187
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
722
Price
$329.71
Total Value
$238.05K
Shares Held After
99,533
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
424
Price
$328.71
Total Value
$139.37K
Shares Held After
100,255
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
1,399
Price
$327.67
Total Value
$458.41K
Shares Held After
100,679
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
1,669
Price
$326.81
Total Value
$545.45K
Shares Held After
102,078
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
1,098
Price
$325.63
Total Value
$357.54K
Shares Held After
103,747
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
382
Price
$324.65
Total Value
$124.02K
Shares Held After
104,845
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
200
Price
$323.62
Total Value
$64.72K
Shares Held After
105,227
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
37
Price
$332.64
Total Value
$12.31K
Shares Held After
23,512
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
94
Price
$331.93
Total Value
$31.20K
Shares Held After
23,549
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
81
Price
$330.85
Total Value
$26.80K
Shares Held After
23,643
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
170
Price
$329.71
Total Value
$56.05K
Shares Held After
23,724
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
100
Price
$328.71
Total Value
$32.87K
Shares Held After
23,894
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
329
Price
$327.67
Total Value
$107.80K
Shares Held After
23,994
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
392
Price
$326.81
Total Value
$128.11K
Shares Held After
24,323
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
258
Price
$325.63
Total Value
$84.01K
Shares Held After
24,715
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
24,973
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
25,063
% of Holdings
0.2%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
4,198
Price
$1.43
Total Value
$6.00K
Shares Held After
170,736
% of Holdings
2.4%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
2,461
Price
$1.43
Total Value
$3.52K
Shares Held After
174,934
% of Holdings
1.4%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
3,068
Price
$1.43
Total Value
$4.39K
Shares Held After
177,395
% of Holdings
1.7%
Pulmonx Corp (LUNG)
Radhakrishnan Srikanth — Chief Science &Techn. Officer
Shares
756
Price
$1.43
Total Value
$1.08K
Shares Held After
180,463
% of Holdings
0.4%
Penumbra Inc (PEN)
Yuen Maggie — Chief Financial Officer
Shares
2,432
Price
$342.30
Total Value
$832.47K
Shares Held After
18,353
% of Holdings
11.7%
Showing 1901–1950 of 2353 transactions (page 39 of 48)